These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism. Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502 [TBL] [Abstract][Full Text] [Related]
6. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Brandt RR; Heublein DM; Aarhus LL; Lewicki JA; Burnett JC Am J Physiol; 1995 Jul; 269(1 Pt 2):H326-31. PubMed ID: 7631865 [TBL] [Abstract][Full Text] [Related]
7. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312 [TBL] [Abstract][Full Text] [Related]
8. Relationship between the suppressive actions on intestinal absorption and on cGMP production for the natriuretic peptide family in dogs. Kagawa K; Suzuki S; Matsushita K; Uemura N; Morita H; Hosomi H Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):83-92. PubMed ID: 8039275 [TBL] [Abstract][Full Text] [Related]
9. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG Am J Physiol; 1995 Jan; 268(1 Pt 2):R201-7. PubMed ID: 7840321 [TBL] [Abstract][Full Text] [Related]
10. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. Wei CM; Kim CH; Miller VM; Burnett JC J Clin Invest; 1993 Oct; 92(4):2048-52. PubMed ID: 8408658 [TBL] [Abstract][Full Text] [Related]
11. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]
13. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942 [TBL] [Abstract][Full Text] [Related]
14. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Imura H; Nakao K; Itoh H Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000 [TBL] [Abstract][Full Text] [Related]
15. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483 [TBL] [Abstract][Full Text] [Related]
16. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930 [TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate. Kohno M; Horio T; Yokokawa K; Kurihara N; Takeda T Hypertension; 1992 Apr; 19(4):320-5. PubMed ID: 1313393 [TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384 [TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo. Brandt RR; Mattingly MT; Clavell AL; Barclay PL; Burnett JC Hypertension; 1997 Aug; 30(2 Pt 1):184-90. PubMed ID: 9260978 [TBL] [Abstract][Full Text] [Related]
20. Vascular action of circulating and local natriuretic peptide systems is potentiated in obese/hyperglycemic and hypertensive rats. Yoshimoto T; Naruse M; Naruse K; Arai K; Imaki T; Tanabe A; Seki T; Hirose S; Muraki T; Demura H Endocrinology; 1996 Dec; 137(12):5552-7. PubMed ID: 8940383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]